Investigating the MIND diet's effects on cognitive impairment in breast cancer survivors
The MIND-BC Study: MIND diet for Breast cancer Cognition
This study is looking at whether following the MIND diet can help improve memory and focus for breast cancer survivors who are having trouble with thinking clearly after treatment, making it a friendly and practical way to boost their brain health and overall well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11098885 on NIH RePORTER |
What this research studies
This research focuses on how the MIND diet, which combines elements of the Mediterranean and DASH diets, may help improve cognitive function in breast cancer survivors experiencing cancer-related cognitive impairment (CRCI). The study will evaluate the impact of this dietary intervention on cognitive outcomes such as memory and attention, as well as its potential to reduce inflammation and oxidative stress. Participants will be monitored over several years to assess changes in cognitive abilities and overall quality of life. The approach is designed to be accessible and practical for survivors, aiming to provide a sustainable dietary option that could enhance their cognitive health.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer survivors who are experiencing cognitive impairment following their treatment.
Not a fit: Patients who are not breast cancer survivors or those without cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective dietary strategies that improve cognitive function and quality of life for breast cancer survivors.
How similar studies have performed: Previous research has shown that the MIND diet can improve cognitive outcomes in various populations, suggesting a promising avenue for addressing CRCI in breast cancer survivors.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Crowder, Sylvia — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Crowder, Sylvia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.